Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma

The key factors leading to transformed follicular lymphoma (t-FL) include the aberrations of epigenetic modifiers as early and driving events, especially mutations in the gene encoding for histone acetyltransferase. Therefore, reversal of this phenomenon by histone deacetylase (HDAC) inhibitors is e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Mengya, Tan, Jinshui, Pan, Guangchao, Jiang, Yuelong, Zhou, Hui, Lai, Qian, Chen, Qinwei, Fan, Liyuan, Deng, Manman, Xu, Bing, Zha, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677934/
https://www.ncbi.nlm.nih.gov/pubmed/34926293
http://dx.doi.org/10.3389/fonc.2021.780118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677934/
https://www.ncbi.nlm.nih.gov/pubmed/34926293
http://dx.doi.org/10.3389/fonc.2021.780118

Ejemplares similares